Piramal Life Sciences CEO Somesh Sharma On Managing Risk And India's Potential For Discovering New Drugs: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Piramal Life Sciences CEO Somesh Sharma keeps a very low profile and does not speak much about his three decades of leading start-ups in the U.S., but his passion for research has fueled the determination of the Piramal Healthcare group to discover and develop a new molecular compound - which would be a first for India's pharma industry.
You may also be interested in...
Piramal Life Sciences CEO Somesh Sharma On Managing Risk And India's Potential For Discovering New Drugs: An Interview With PharmAsia News (Part 1 of 2)
Piramal Life Sciences CEO Somesh Sharma keeps a very low profile and does not speak much about his three decades of leading start-ups in the U.S., but his passion for research has fueled the determination of the Piramal Healthcare group to discover and develop a new molecular compound - which would be a first for India's pharma industry.
Regenerative Meds: Indian Drug Makers Inject New Life Through Investments In Stem Cells
MUMBAI - Leading Indian companies are gearing up for emerging frontiers in medicine research, and among all the segments, regenerative therapies seem to be driving more and more initial investments from mainstream pharma companies
Pfizer, Lilly And Merck Strike Up Cancer Research Partnership In Asia
Eli Lilly, Pfizer and Merck - like many Big Pharma - are hoping to spur growth in the future by addressing unmet medical need in Asia's emerging markets. The three companies hope to accelerate research in addressing Asia's most-commonly diagnosed cancers with a non-competitive collaboration - perhaps the first of its kind in the region - to share data for the next several years